Respiratory Syncytial Virus Attachment Glycoprotein Market to Witness Growth Acceleration by 2029
The global respiratory syncytial virus attachment glycoprotein market is anticipated to grow at a significant CAGR during the forecast period. Respiratory syncytial virus or RSV is a common respiratory virus. It usually causes mild, cold-like symptoms and most people recover in a week or two, however, it is very serious especially for infants and older adults. The major factor accelerating the growth of the market is the increasing prevalence of respiratory syncytial virus (RSV) attachment glycoprotein across the globe. According to the National Institute of Allergy and Infectious Disease (NIH), almost all children become infected with RSV by age 2. Additionally, an estimated 75,000 to 125,000 of them are hospitalized each year. Furthermore, it affects an estimated 64 million people with a mortality rate of 160,000 each year. Hence, the rising incidence of the disease is driving the growth of the global respiratory syncytial virus attachment glycoproteins market during the forecast period.
Some major players operating in the market include Bavarian
Nordic A/S, Sanofi S.A., and F. Hoffmann-La Roche Ltd., among others. The market
players are contributing significantly to the growth of the market by the
adoption of various strategies including mergers & acquisitions,
geographical expansion, partnerships and collaborations, and new product
launches, to stay competitive in the market. For instance, in June 2021, Sanofi
announced Nirsevimab being developed in partnership with AstraZeneca. It is the
first investigational extended half-life monoclonal antibody (mAb) that aims to
protect all infants who enter the first RSV season when they are at the highest
risk for severe RSV disease.
To Request a Sample of our Report on Respiratory
Syncytial Virus Attachment Glycoprotein Market: https://www.omrglobal.com/request-sample/respiratory-syncytial-virus-attachment-glycoprotein-market
Market Coverage
•
The market number available for – 2021-2029
•
Base year- 2021
•
Forecast period- 2023-2029
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-
Bavarian Nordic A/S, Sanofi S.A., and F. Hoffmann-La Roche Ltd., among others.
Respiratory Syncytial Virus Attachment Glycoprotein
Market Report by Segment
By Type
• VIS-RSV
• TRL-3D3
• AX-14
• MVA-RSV
• Others
By Application
• Clinics
• Hospitals
• Others
A
full Report of Respiratory Syncytial Virus Attachment Glycoprotein Market is Available
@ https://www.omrglobal.com/industry-reports/respiratory-syncytial-virus-attachment-glycoprotein-market
Respiratory
Syncytial Virus Attachment Glycoprotein Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment